The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood

被引：0
作者：
Chrissa Sioka
机构：
[1] University of Ioannina,Neurosurgical Research Institute
来源：
European Journal of Pediatrics | 2013年 / 172卷
关键词：
PET; Lymphoma; Hodgkin lymphoma; Non-Hodgkin lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are among the most common malignancies of childhood. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) can be employed for accurate staging, treatment planning, and response assessment in pediatric patients with lymphomas, taking advantage of the increased FDG uptake of the malignant cells, secondary to their increased metabolic needs. FDG PET has higher sensitivity than other imaging modalities to detect nodular or diffuse lesions and higher sensitivity than bone marrow biopsy to detect bone marrow infiltration. FDG PET consists of an invaluable imaging modality during evaluation and treatment of pediatric lymphomas.
引用
收藏
页码：733 / 738
页数：5
相关论文
共 395 条
[21]  
Marwaha RK(2012)SUV-measurements and patient-specific corrections thereof in pediatric Hodgkin lymphoma: is there a benefit for PPV in early response assessment by FDG-PET? Pediatr Blood Cancer 43 8-16
[22]  
Alessio AM(2009)Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin’s lymphoma: analysis of a prospective multicenter trial J Clin Oncol 44 1-7
[23]  
Kinahan PE(2004)Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol Pediatr Blood Cancer 36 524-531
[24]  
Manchanda V(2005)Staging in childhood lymphoma: differences between FDG-PET and CT Nuklearmedizin 51 198-203
[25]  
Ghioni V(2006)F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas Pediatr Radiol 17 230-242
[26]  
Aldape L(2008)Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma Pediatr Blood Cancer 15 1631-1637
[27]  
Parisi MT(2007)Pediatric Hodgkin lymphoma: maximizing efficacy and minimizing toxicity Semin Radiat Oncol 322 7-13
[28]  
Andolino DL(1997)Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin’s lymphoma treated with high-dose CHOP chemotherapy J Clin Oncol 119 4129-4132
[29]  
Hoene T(1990)Leukemia following Hodgkin’s disease N Engl J Med 35 141-154
[30]  
Xiao L(2012)A phase II study of rituximab-ABVD in classical Hodgkin lymphoma Blood 23 315-340
12345678910